The DOI matches its Crossref record; 32 of the 35 references it cites were found in a registry or an index.
Fibroblast Matrix Gene Expression and Connective Tissue Remodeling: Role of Endothelin-1
Open accessAbstract
This study examines endothelin-induced modulation of extracellular matrix synthesis and remodeling by fibroblasts, and its potential role in the pathogenesis of systemic sclerosis (scleroderma). Endothelin-1 promoted fibroblast synthesis of collagen types I and III, but not fibronectin, by a mechanism dependent upon both ETA and ETB receptors. Conversely, endothelin-1 inhibited both protein expression of matrix metalloproteinase 1 and zymographic activity exclusively via ETA receptors. A dual regulatory role for endothelin-1 in transcriptional regulation was suggested by the ability of endothelin-1 to enhance steady-state levels of collagen mRNA and activate the proalpha2(I) collagen (Col1a2) promoter, but in contrast to reduce matrix metalloproteinase 1 transcript expression and suppress transcription of a human matrix metalloproteinase 1 promoter reporter construct in transient transfection assays. Although endothelin-1 significantly enhanced remodeling of three-dimensional collagen lattices populated by normal fibroblasts, this was not observed for lattices populated by systemic sclerosis fibroblasts. Promotion of matrix remodeling was dependent upon ETA receptor expression and was blocked by specific inhibitors of tyrosine kinases or protein kinase C. Reverse transcriptase polymerase chain reaction, S1 nuclease, and functional cell surface binding studies showed that normal and systemic sclerosis fibroblasts express both ETA and ETB receptors (predominantly ETA), but that ETA receptor mRNA levels and ETA binding sites on fibroblasts cultured from systemic sclerosis skin biopsies are reduced by almost 50%. Endothelin-1 is thus able to induce a fibrogenic phenotype in normal fibroblasts that is similar to that of lesional systemic sclerosis fibroblasts. Moreover, reduced responsiveness to exogenous endothelin-1 in systemic sclerosis suggests that downstream pathways may have already been activated in vivo. These data further implicate dysregulated endothelin-receptor pathways in fibroblasts in the pathogenesis of connective tissue fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The differentially regulated genes included several mediators of vascular wall integrity and structure, such as COL4A1, COL3A1, and FN1 (Figure S4E), which may be downstream effects of increased EDN1 expression in the G/G ESC-ECs (Amiri et al., 2004; Shi-Wen et al., 2001).”
From A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression (2017) · cites this paper as Shi-Wen et al., 2001
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,925
Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.
Rubanyi, G. M., & Polokoff, M. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06809-7 · Cited by 1,645
Fibroblasts, myofibroblasts, and wound contraction
Grinnell, F. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.4.401 · Cited by 1,141
Levin, E. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330607 · Cited by 711
LeRoy, E. C. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107827 · Cited by 543
Hocher, B., Thöne‐Reineke, C., Rohmeiss, P., Schmager, F., Slowinski, T., Burst, V. R., Siegmund, F., Quertermous, T., Bauer, C., Neumayer, H.-H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119297 · Cited by 411
Langholz, O., Roeckel, D., Mauch, C., Kozlowska, E., Bank, I., Krieg, T., & Eckes, B. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.6.1903 · Cited by 397
Barton, M., Haudenschild, C. C., d’Uscio, L. V., Shaw, S., Münter, K., & Lüscher, T. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14367 · Cited by 356
Effects of endothelins on collagen turnover in cardiac fibroblasts
Eduardo Guarda, S., Katwa, L. C., Myers, P. R., Tyagi, S. C., & Weber, K. T. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2130 · Cited by 291
Cited by
Sorted by citations
Items 101–200 of 243
Hartopo, A. B., Arfian, N., Nakayama, K., SUZUKI, Y., Yagi, K., & Emoto, N. (2018) · Physiological Research · doi:10.33549/physiolres.933812 · Cited by 34
Jiménez, S. A. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-eular.6222 · Cited by 34
Role of endothelin-1 in the skin fibrosis of systemic sclerosis
Jing, J., Dou, T., Yang, J. Q., Chen, X. B., Cao, H.-L., Min, M., Cai, S., Zheng, M., & Man, X. (2015) · European Cytokine Network · doi:10.1684/ecn.2015.0360 · Cited by 33
Assessment of atrial fibrosis for the rhythm control of atrial fibrillation
Begg, G. A., Holden, A. V., Lip, G. Y. H., Plein, S., & Tayebjee, M. H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.144 · Cited by 33
Endothelin-1, α-Klotho, 25(OH) Vit D levels and severity of disease in scleroderma patients
Hajialilo, M., Noorabadi, P., Tekantapeh, S. T., & Mahdavi, A. M. (2017) · Rheumatology International · doi:10.1007/s00296-017-3797-z · Cited by 33
Localization of endothelin receptors in bleomycin-induced pulmonary fibrosis in the rat
Wendel, M., Petzold, A., Koslowski, R., Kasper, M. E., Augstein, A., Knels, L., Bleyl, J.-U., & Koch, T. (2000) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0708-7 · Cited by 32
Meehan, D. T., Delimont, D. C., Dufek, B. M., Zallocchi, M., Phillips, G. W., Gratton, M. A., & Cosgrove, D. E. (2016) · Hearing Research · doi:10.1016/j.heares.2016.08.003 · Cited by 31
Kocken, J. M. M., & Martins, P. A. D. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238901 · Cited by 30
Review: New perspectives in the treatment of idiopathic pulmonary fibrosis
Rogliani, P., Mura, M., Porretta, M. A., & Saltini, C. (2008) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465808089363 · Cited by 30
Corallo, C., Franci, B., Lucani, B., Montella, A., Chirico, C. D., Gonnelli, S., Nuti, R., & Giordano, N. G. (2015) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632015572750 · Cited by 28
Resveratrol and Cardiac Fibrosis Prevention and Treatment
Zivarpour, P., Reiner, Ž., Hallajzadeh, J., & Mirsafaei, L. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210212125003 · Cited by 27
Iribarne, M., Ogawa, L., Torbidoni, V., Dodds, C. M., Dodds, R. A., & Suburo, Á. M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070605 · Cited by 27
Callegari, E. A., Ferguson-Gottschall, S., & Gibori, G. (2005) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-3-3 · Cited by 27
Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis
Hua-Huy, T., & Dinh‐Xuan, A. T. (2015) · Pathologie Biologie · doi:10.1016/j.patbio.2015.03.003 · Cited by 26
The Nax (SCN7A) channel: an atypical regulator of tissue homeostasis and disease
Dolivo, D., Rodrigues, A. E., Sun, L. S., Li, Y., Hou, C., Galiano, R. D., Hong, S. J., & Mustoe, T. A. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03854-2 · Cited by 26
Soares, T. D. J., Costa, R. S., Volpini, R. A., da Silva, C. G. A., & Coimbra, T. M. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00223.x · Cited by 26
Vallender, T. W., & Lahn, B. T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.07.017 · Cited by 26
Emerging drugs for idiopathic pulmonary fibrosis
Selman, M., Pardo, A., Richeldi, L., & Cerri, S. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.565049 · Cited by 26
FURUYA, Y., & Kuwana, M. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110499 · Cited by 25
Santalucı́a, T. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00472-3 · Cited by 25
Vrancianu, C., Gheorghiu, A. M., Popa, D. E., Chan, J. S. K., Satti, D. I., Lee, Y. H. A., Hui, J. M. H., Tse, G., Ancuta, I., Ciobanu, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112963 · Cited by 24
Expression and function of ETA and ETB receptors in SSc
Frommer, K., & Müller‐Ladner, U. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken274 · Cited by 24
Waters, C. E., Shiwen, X., Denton, C., Abraham, D., & Pearson, J. D. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21572 · Cited by 24
Pasdaran, A., Azarpira, N., Heidari, R., Nourinejad, S., Zare, M., & Hamedi, A. (2022) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.14695 · Cited by 24
Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure
Jiang, B. H., Tardif, J., Shi, Y., & Dupuis, J. (2010) · European Respiratory Journal · doi:10.1183/09031936.00053710 · Cited by 23
Manitsopoulos, N., Nikitopoulou, I., Maniatis, N. A., Μagkou, C., Kotanidou, A. N., & Orfanos, S. E. (2017) · Respiration · doi:10.1159/000481201 · Cited by 23
Chen, X., Lu, G., Tang, K., Li, Q., & Gao, X. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.03.003 · Cited by 22
Richard, V. J., Solans, V., Favre, J., Henry, J., Lallemand, F., Thuillez, C., & Marié, I. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00634.x · Cited by 22
The manifestations of vasculopathy in systemic sclerosis and its evidence‐based therapy
Strange, G. A., & Nash, P. T. (2009) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2009.01410.x · Cited by 22
Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies
Rudman-Melnick, V., & Blaxall, B. C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.01.020 · Cited by 22
Peterlana, D., Puccetti, A., Caramaschi, P., Biasi, D., Beri, R., Simeoni, S., Corrocher, R., & Lunardi, C. (2006) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740500385584 · Cited by 22
van der Vlag, J., & Buijsers, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34521-1_26 · Cited by 21
Current and emerging drugs for idiopathic pulmonary fibrosis
Gharaee‐Kermani, M., Hu, B., Thannickal, V. J., Phan, S. H., & Gyetko, M. R. (2007) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.12.4.627 · Cited by 21
Hypoxia and chronic kidney disease: Possible mechanisms, therapeutic targets, and relevance to cats
Spencer, S., Wheeler-Jones, C. P. D., & Elliott, J. (2021) · The Veterinary Journal · doi:10.1016/j.tvjl.2021.105714 · Cited by 20
Meijs, J., Voskuyl, A. E., Bloemsaat-Minekus, J. P. J., & Vonk, M. C. (2014) · Lara D. Veeken · doi:10.1093/rheumatology/keu300 · Cited by 20
Role of endothelin in lung fibrosis
Abraham, D. (2008) · European Respiratory Review · doi:10.1183/09059180.00010907 · Cited by 20
Arvia, R., Margheri, F., Stincarelli, M. A., Laurenzana, A., Fibbi, G., Gallinella, G., Ferri, C., Rosso, M. D., & Zakrzewska, K. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa230 · Cited by 20
Emerging drugs for idiopathic pulmonary fibrosis
Thannickal, V. J., Flaherty, K. R., Hyzy, R. C., & Lynch, J. P. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.4.707 · Cited by 20
Desantis, V., Potenza, M. A., Sgarra, L., Nacci, C., Scaringella, A., Cicco, S., Solimando, A. G., Vacca, A., & Montagnani, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065307 · Cited by 19
Dual ETA/ETBvs. selective ETAendothelin receptor antagonism in patients with pulmonary hypertension
Opitz, C. F., & Ewert, R. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01691.x · Cited by 19
Ahmed, S. S., & Tan, F. K. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200311000-00014 · Cited by 19
Li, X., Qiu, J., Pan, M., Zheng, D., Su, Y., Wei, M., Kong, X., Sun, W., & Zhu, J. (2015) · PubMed Central · Cited by 18
Endothelin receptor selectivity: evidence fromin vitroand pre‐clinical models of scleroderma
Shiwen, X., Leask, A., Abraham, D., & Fonseca, C. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02117.x · Cited by 18
Masi, I., Ottavi, F., Caprara, V., Rio, D. D., Kunkl, M., Spadaro, F., Licursi, V., Tuosto, L., Bagnato, A., & Rosanò, L. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03327-5 · Cited by 17
Endothelin-1 in systemic sclerosis
Shojaa, M., Aghaei, M., Gharibdoost, F., Zayeni, H., Akhlaghi, M., Sedighi, S., Rostamian, A., & Aghdami, N. (2012) · Indian Dermatology Online Journal · doi:10.4103/2229-5178.93484 · Cited by 17
Jullien, N. D., Blirando, K., Milliat, F., Sabourin, J., Benderitter, M., & François, A. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.12.086 · Cited by 17
Humbert, M. J. C., & Simonneau, G. (2005) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0048 · Cited by 17
Endothelin‐1 mediates Aspergillus fumigatus‐induced airway inflammation and remodelling
Labram, B., Namvar, S., Hussell, T., & Herrick, S. E. (2019) · Clinical & Experimental Allergy · doi:10.1111/cea.13367 · Cited by 16
Solini, A., Santini, E., Madec, S., Cuccato, S., & Ferrannini, E. (2007) · Growth Factors · doi:10.1080/08977190801892341 · Cited by 16
Dominant role of CACNA1D exon mutations for blood pressure regulation
Wang, H., Zhu, J., Cheng, L., Mao, G., Chen, H., Wu, X., Hong, H., Wang, C., Lin, P., Chen, J., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003085 · Cited by 15
RETINAL DETACHMENT AND PROLIFERATIVE VITREORETINOPATHY
Pallarés, M. R., Musa, A.-S., HERNANDEZ‐MONTERO, J., Rollín, R., Bravo-Llatas, C., & Fernández-Durango, R. (2008) · Retina · doi:10.1097/iae.0b013e31809ffad0 · Cited by 15
ETAand ETBreceptors are expressed in vascular adventitial fibroblasts
Boyd, R., Rätsep, M. T., Ding, L. L., & Wang, H. D. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00869.2010 · Cited by 14
Clozel, M., & Flores, S. (2006) · Drug Development Research · doi:10.1002/ddr.20156 · Cited by 14
A case of scleredema adultorum successfully treated with narrow-band ultraviolet B phototherapy
Yoshimura, J., Asano, Y., Takahashi, T., Uwajima, Y., Kagami, S., Honda, H., Idezuki, T., Igarashi, A., & Sato, S. (2014) · Modern Rheumatology · doi:10.3109/14397595.2013.875640 · Cited by 14
RETINAL DETACHMENT AND PROLIFERATIVE VITREORETINOPATHY
Pallarés, M. R., Musa, A.-S., HERNANDEZ‐MONTERO, J., Bravo-Llatas, C., & Fernández-Durango, R. (2013) · Retina · doi:10.1097/iae.0b013e318285cbef · Cited by 14
Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice
Akashi, K., Saegusa, J., Sendo, S., Nishimura, K., Okano, T., Yagi, K., Yanagisawa, M., Emoto, N., & Morinobu, A. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1011-4 · Cited by 16
Argentino, G., Barbieri, A., Beri, R., Bason, C., Ruzzenente, A., Olivieri, O., Tinazzi, E., Puccetti, A., Vitali, C., Papa, N. D., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10112765 · Cited by 13
Haro, J. D., Bleda, S., Varela, C., Esparza, L., & Acín, F. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.10.032 · Cited by 13
Swope, V. B., & Boyce, S. T. (2005) · Journal of Surgical Research · doi:10.1016/j.jss.2005.03.018 · Cited by 13
Expression and bioactivities of endothelin‐1 in gingiva during cyclosporine A treatment
Chin, Y., Tu, H., Chen, Y., Dai, N., Shen, E., Chiang, C., Fu, M. M.-J., & Fu, E. (2008) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2007.01058.x · Cited by 11
Giannelli, G., Iannone, F., Marinosci, F., Lapadula, G., & Antonaci, S. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01686.x · Cited by 11
Future targets in the management of systemic sclerosis
Tyndall, A., Matucci‐Cerinic, M., & Müller‐Ladner, U. (2006) · Rheumatology · doi:10.1093/rheumatology/kep106 · Cited by 11
Préfontaine, A., Calderone, A., & Dupuis, J. (2008) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-024 · Cited by 11
D-dimer and pulmonary arterial hypertension in systemic sclerosis.
Kiatchoosakun, S., Ungkasekvinai, W., Wonvipaporn, C., Tatsanavivat, P., Foocharoen, C., Suwannaroj, S., & Nanagara, R. (2007) · PubMed · Cited by 10
Kalk, P., Rückert, M., Godes, M., von Websky, K., Relle, K., Neumayer, H.-H., Hocher, B., & Morgera, S. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp652 · Cited by 9
Development of macitentan for the treatment of pulmonary arterial hypertension
Selej, M., Romero, A., Channick, R. N., & Clozel, M. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12856 · Cited by 9
Haro, J. D., Bleda, S., Gonzalez‐Hidalgo, C., Michel, I., & Acín, F. (2018) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-018-0307-y · Cited by 9
NAGATA, T., Kudo, H., Nishino, T., Doi, Y., Itoh, H., & Fujimoto, S. (2005) · Medical Molecular Morphology · doi:10.1007/s00795-005-0292-5 · Cited by 9
The role of endothelin-1 and its receptor blockers on the liver function
Michalski, Ł., Kleniewska, P., Piechota-Polańczyk, A., & Gorąca, A. (2012) · General Physiology and Biophysics · doi:10.4149/gpb_2012_046 · Cited by 8
Endothelin-1 and endothelin receptors in the basilar artery of the capybara
Loesch, A., Gajkowska, B., Dashwood, M. R., Fioretto, E. T., Gagliardo, K. M., de Lima, A. R., & Ribeiro, A. A. C. M. (2005) · The Histochemical Journal · doi:10.1007/s10735-004-2912-0 · Cited by 8
Kubysheva, N. I., POSTNIKOVA, L. B., Келдибековна, С. С., Vv, N., Shumilova, S. V., Kasatova, E. S., Eliseeva, T. I., Игнатов, С. К., Li, T. V., & Batyrshin, I. (2017) · Современные технологии в медицине · doi:10.17691/stm2017.9.2.13 · Cited by 7
Updates in the Diagnosis and Treatment of Vasculitis
Sakkas, L. I., & Katsiari, C. G. (2013) · InTech eBooks · doi:10.5772/46068 · Cited by 7
Pulmonary hypertension in systemic sclerosis: bete noire no more?
Varga, J. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200211000-00007 · Cited by 7
Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives
Vancheri, C., Sciacca, E., Muscato, G., Spicuzza, L., Fruciano, M., Gili, E., Sambataro, G., Palmucci, S., & Libra, A. (2024) · Multidisciplinary Respiratory Medicine · doi:10.5826/mrm.2024.982 · Cited by 7
Dietary flavonoid apigenin inhibits endothelin-1-induced contraction of collagen gel
Jun, J., Na, Y.-I., Kim, T., & Yoo, D. (2009) · Rheumatology International · doi:10.1007/s00296-009-1285-9 · Cited by 5
Kuwana, M. (2004) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.27.118 · Cited by 5
Elucidating the causes and examining the latest clinical findings in pulmonary fibrosis
King, T. E., & du Bois, R. M. (2008) · European Respiratory Review · doi:10.1183/09059180.00010901 · Cited by 5
Pharmacotherapy in patients with idiopathic pulmonary fibrosis
Nagai, S., Handa, T., & Kim, D. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.11.1909 · Cited by 5
Pan, X., Wang, Y., Lübke, T., Hinek, A., & Pshezhetsky, A. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172854 · Cited by 5
Treatment of Scleroderma with Para-Aminobenzoic Acid: Effect on Disease Morbidity.
Sawalha, K. (2018) · Archives of General Internal Medicine · doi:10.4066/2591-7951.1000052 · Cited by 5
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis
Spagnolo, P., Luppi, F., Montanari, G., & Richeldi, L. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-682-5_14 · Cited by 4
Ling, Y., Li, C., Purslow, C., Yang, Y., & Huang, Z. (2019) · Optical Elastography and Tissue Biomechanics · doi:10.1117/12.2509486 · Cited by 4
Blocking endothelin: breaking new ground
du Bois, R. M. (2007) · European Respiratory Review · doi:10.1183/09059180.00010206 · Cited by 4
Analysis of immunostaining and western blotting of endothelin 1 and its receptors in mitral stenosis
Leão, S. C., Dashwood, M. R., Andrade, M., Santos, N. N., Teles, O. R. L. L., de Souza, W. B., & Rodrigues, T. M. D. A. (2015) · Brazilian Journal of Cardiovascular Surgery · doi:10.5935/1678-9741.20150004 · Cited by 3
Soares, T. D. J., Costa, R. S., Coelho, R. D. M., da Silva, C. G. A., & Coimbra, T. M. (2005) · Renal Failure · doi:10.1080/08860220500244781 · Cited by 3
Bosentan et fibrose pulmonaire
Cottin, V., & Cordier, J. F. (2007) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(07)80022-1 · Cited by 3
Endothéline-1 et crise rénale sclérodermique
Terrier, B., Guillevin, L., & Mouthon, L. (2007) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(07)80023-3 · Cited by 3
Treatment of Pulmonary Arterial Hypertension With the Endothelin Receptor Antagonist Bosentan
Taichman, D. B., & Palevsky, H. I. (2005) · Clinical Pulmonary Medicine · doi:10.1097/01.cpm.0000156278.12579.44 · Cited by 3
Endothéline 1 et sélectivité des antagonistes des récepteurs de l’endothéline 1 : to B or not to B ?
Marié, I., Bekri, S., & Levesque, H. (2008) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2008.01.001 · Cited by 3
Bosentan therapy for cutaneous fibrosis in systemic sclerosis
Sancho, J. J. A., Román‐Ivorra, J. A., Verdejo, C. C., Fernández‐Carballido, C., Fernández-Llanio, N., Cortés, J. I., Alonso, R. H., Escandell, C. A., Abad‐Franch, L., Pascual, E. V., et al. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x199754 · Cited by 3
Vasculitis and Vasculopathy in Rheumatic Diseases
Radić, M., & Radić, J. (2013) · InTech eBooks · doi:10.5772/55056 · Cited by 2
L’endothéline : de la découverte aux avancées pharmacothérapeutiques
Richard, V. J. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.01.015 · Cited by 2
High expression of CD40 on skin fibroblasts from patients with systemic sclerosis
Jun, J., Kim, T., Na, Y.-I., & Yoo, D. (2007) · Rheumatology International · doi:10.1007/s00296-007-0393-7 · Cited by 2
Bosentan for the treatment of scleroderma
HACHULLA, E., Launay, D., & Humbert, M. J. C. (2006) · Future Rheumatology · doi:10.2217/17460816.1.5.549 · Cited by 2
Wang, Y., Altorok, N., & Kahaleh, B. (2016) · Journal of Scleroderma and Related Disorders · doi:10.5301/jsrd.5000210 · Cited by 1
Jun, J., Kim, J. K., Na, Y.-I., Han, H., Paik, S. S., Kim, S., & Kim, Y. (2012) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2012.19.4.206 · Cited by 1
Role of TRPC and Orai Channels in Vascular Remodeling
Poteser, M., Krenn, S., & Groschner, K. (2013) · Springer eBooks · doi:10.1007/978-3-642-40282-1_23 · Cited by 1
Tanaka, S., Mori, M., Ehara, Y., Adachi, M., & Sumitomo, S. (2016) · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · doi:10.1016/j.ajoms.2016.09.002 · Cited by 1
Cardiac Microvascular Endothelial Cells and Pressure Overload-Induced Cardiac Fibrosis
Al‐Hasani, J., & Hecker, M. (2023) · Cardiac and vascular biology · doi:10.1007/978-3-031-23965-6_10 · Cited by 1
Endothelin-1-Promoting Actions in the Growth and Angiogenesis of Solid Cancers
Loizidou, M. (2008) · Springer eBooks · doi:10.1007/978-1-84628-919-4_15 · Cited by 1
Metadata
- Authors
- Shi-wen, X., Denton, C. P., Holmes, A. M., Black, C. M., Abraham, D. J., Dashwood, M. R., Bou-Gharios, G., & Pearson, J. D.
- Affiliations
- The Royal Free Hospital (GB)
- King's College London (GB)
- Corresponding author
- Abraham, David J.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 116
- Issue
- 3
- Pages
- 417-425
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2064485592
- Cited by
- 243
- References
- 35
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 10 · 2015: 13 · 2014: 11 · 2013: 12 · 2012: 6
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Investigative Dermatology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- endothelin-1, systemic sclerosis, fibroblasts, extracellular matrix remodeling, collagen synthesis, type I collagen, type III collagen, fibronectin, MMP-1, ETA receptor, endothelin B receptor, connective tissue fibrosis, tyrosine kinase inhibitors, protein kinase C
- MeSH terms
- Cells, Cultured, Collagen, Connective Tissue, Extracellular Matrix, Fibroblasts, Humans, Reference Values, RNA, Messenger, Scleroderma, Systemic, Transcription, Genetic, Gene Expression, Receptors, Endothelin, Endothelin-1, Matrix Metalloproteinase 1, Receptor, Endothelin A, Receptor, Endothelin B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review